New PSA campaign to raise awareness about autoimmune diseases

NewsGuard 100/100 Score

The American Autoimmune Related Diseases Association Inc. (AARDA) has unveiled a multi-media public service/awareness campaign titled "We are 50 Million" to herald March 2011 as National Autoimmune Diseases Awareness Month.

The campaign is designed to educate the general public about the magnitude of autoimmune disease and its impact on patients, families and the U.S. health care system. It spotlights the more than 100 known autoimmune diseases and the 50 million Americans who suffer from them, as well as the latest methods of diagnosis and treatment, and the most promising research on the horizon.

The "We are 50 Million" campaign features television and radio public service announcements (PSAs) to air on national satellite, cable and radio networks, as well as patient stories aimed at traditional, new and social media outlets.

Other 2011 National Autoimmune Diseases Awareness Month events scheduled by AARDA include:

● A U.S. Capitol Hill Briefing to members of Congress to present the report "The Autoimmune Epidemic: The Financial Burden of Autoimmune Diseases to Your Constituents and the Health Care System" on March 22 in collaboration with the National Coalition of Autoimmune Patient Groups.

● A free public forum in New York City titled "What Every American Needs to Know about Autoimmune Disease" on March 26 at New York University's Langone Medical Center.

● A mobile texting campaign to support autoimmunity research. Supporters are encouraged to text A-A-R-D-A to 20222 and donate $5.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer